Biomerica, Inc. (BMRA) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
BMRA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BMRA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 9.4% | -96.7% | -93.6% |
| 2024 | 11.3% | -117.6% | -110.4% |
| 2023 | 8.4% | -135.3% | -133.7% |
| 2022 | 15.8% | -24.0% | -24.0% |
| 2021 | 5.1% | -104.2% | -103.4% |
Download Data
Export BMRA earnings history in CSV or JSON format
Free sign-in required to download data
Biomerica, Inc. (BMRA) Earnings Overview
As of May 9, 2026, Biomerica, Inc. (BMRA) reported trailing twelve-month net income of -$4M, reflecting -500.0% year-over-year growth. The company earned $-1.38 per diluted share over the past four quarters, with a net profit margin of -93.6%.
Looking at the long-term picture, BMRA's historical earnings data spans multiple years. The company achieved its highest annual net income of $2M in fiscal 2008.
Biomerica, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CODX (-$47M net income, -7533.6% margin), QDEL (-$1.21B net income, -41.5% margin), OSUR (-$53M net income, -59.8% margin), BMRA has outperformed on profitability metrics. Compare BMRA vs CODX →
BMRA Earnings vs Peers
Earnings metrics vs comparable public companies
BMRA Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$5M | +16.8% | -$5M | $-2.16 | -93.6% | -96.7% |
| 2024 | -$6M | +16.3% | -$6M | $-0.36 | -110.4% | -117.6% |
| 2023 | -$7M | -57.6% | -$7M | $-0.50 | -133.7% | -135.3% |
| 2022 | -$5M | +39.2% | -$5M | $-0.36 | -24.0% | -24.0% |
| 2021 | -$7M | -218.3% | -$7M | $-0.54 | -103.4% | -104.2% |
| 2020 | -$2M | +2.3% | -$2M | $-0.23 | -34.9% | -35.9% |
| 2019 | -$2M | -63.3% | -$2M | $-0.26 | -46.0% | -46.4% |
| 2018 | -$1M | -61.3% | -$1M | $-0.17 | -26.3% | -26.6% |
| 2017 | $-908,561 | +39.4% | $-954,633 | $-0.11 | -15.7% | -16.5% |
| 2016 | -$1M | -352.5% | $-826,952 | $-0.20 | -29.2% | -16.1% |
See BMRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BMRA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BMRA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBMRA — Frequently Asked Questions
Quick answers to the most common questions about buying BMRA stock.
Is BMRA growing earnings?
BMRA EPS fell to $-1.38, with earnings declining -500.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-4M.
What are BMRA's profit margins?
Biomerica, Inc. net margin is -93.6%, with operating margin at -96.7%. Below-average margins reflect competitive or cost pressures.
How consistent are BMRA's earnings?
BMRA earnings data spans 1989-2025. The declining earnings trend is -500.0% YoY. Historical data enables comparison across business cycles.